Literature DB >> 8379716

Pulsatile versus nonpulsatile reperfusion improves cerebral blood flow after cardiac arrest.

M P Anstadt1, M Tedder, S S Hegde, R A Perez-Tamayo, B J Crain, V L Khian Ha, S Abdel-Aleem, W D White, J E Lowe.   

Abstract

Cardiopulmonary bypass using nonpulsatile flow (NF) is currently advocated for treating refractory cardiac arrest. Although the heart can be revived using cardiopulmonary bypass support, the brain must recover if such therapy is to be considered successful. Previous studies have demonstrated that pulsatile flow (PF) reperfusion can improve neurologic outcome compared with NF reperfusion after cardiac arrest. The purpose of this study was to assess cerebral perfusion and oxygen consumption during either PF or NF reperfusion after cardiac arrest. Dogs (n = 22) underwent a 15-minute cardiac arrest followed by 1 hour of either PF or NF reperfusion. Microsphere techniques were used to assess cerebral perfusion and oxygen consumption at 3, 15, and 60 minutes of reperfusion. Mean arteriovenous gradients and total brain flows were similar in both groups. However, cerebral oxygen consumption was significantly improved at 3 minutes of reperfusion with PF versus NF (1.8 +/- 0.3 versus 0.9 +/- 0.3 mL O2.dL-1.min-1, respectively; p < 0.05). These results were coincident with improved gray-to-white flow ratios at 3 minutes of PF versus NF reperfusion (5.2 +/- 1.0 versus 2.0 +/- 0.3, respectively; p < 0.05). There were no statistically significant differences in brain perfusion variables by 15 minutes of reperfusion. However, a relative hyperemia was exhibited at 15 minutes of NF versus PF reperfusion, which suggests nutrient flow was insufficient during early NF versus PF reperfusion. In conclusion, PF reperfusion can better restore cerebral blood flow and oxygen consumption than can NF reperfusion.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1993        PMID: 8379716     DOI: 10.1016/0003-4975(93)90879-m

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  6 in total

Review 1.  Chronic nonpulsatile blood flow is compatible with normal end-organ function: implications for LVAD development.

Authors:  Satoshi Saito; Tomohiro Nishinaka
Journal:  J Artif Organs       Date:  2005       Impact factor: 1.731

2.  Studies of isolated global brain ischaemia: III. Influence of pulsatile flow during cerebral perfusion and its link to consistent full neurological recovery with controlled reperfusion following 30 min of global brain ischaemia.

Authors:  Bradley S Allen; Yoshihiro Ko; Gerald D Buckberg; Zhong Tan
Journal:  Eur J Cardiothorac Surg       Date:  2012-03-20       Impact factor: 4.191

3.  Studies of isolated global brain ischaemia: II. Controlled reperfusion provides complete neurologic recovery following 30 min of warm ischaemia - the importance of perfusion pressure.

Authors:  Bradley S Allen; Yoshihiro Ko; Gerald D Buckberg; Zhong Tan
Journal:  Eur J Cardiothorac Surg       Date:  2012-03-20       Impact factor: 4.191

4.  Change in myocardial oxygen consumption employing continuous-flow LVAD with cardiac beat synchronizing system, in acute ischemic heart failure models.

Authors:  Akihide Umeki; Takashi Nishimura; Yoshiaki Takewa; Masahiko Ando; Mamoru Arakawa; Yuichiro Kishimoto; Tomonori Tsukiya; Toshihide Mizuno; Shunei Kyo; Minoru Ono; Yoshiyuki Taenaka; Eisuke Tatsumi
Journal:  J Artif Organs       Date:  2013-01-17       Impact factor: 1.731

Review 5.  Brain vulnerability and viability after ischaemia.

Authors:  Stefano G Daniele; Georg Trummer; Konstantin A Hossmann; Zvonimir Vrselja; Christoph Benk; Kevin T Gobeske; Domagoj Damjanovic; David Andrijevic; Jan-Steffen Pooth; David Dellal; Friedhelm Beyersdorf; Nenad Sestan
Journal:  Nat Rev Neurosci       Date:  2021-07-21       Impact factor: 34.870

6.  Sleep Quality after Coronary Artery Bypass Graft Surgery: Comparing Pulsatile and Nonpulsatile Pump Flow.

Authors:  Amir Mirmohammadsadeghi; Nahid Jahannama; Mohsen Mirmohammadsadeghi
Journal:  J Extra Corpor Technol       Date:  2020-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.